Fact-checked by Grok 2 weeks ago

Mesotherapy

Mesotherapy, also referred to as local intradermal therapy (LIT), is a medical technique that involves the administration of small doses of medications, vitamins, minerals, enzymes, or other bioactive substances directly into the —the middle layer of the skin (derived from the )—using fine needles to achieve localized therapeutic effects. This method, which can include multiple intradermal or subcutaneous injections over or near the affected area, aims to modulate drug absorption for prolonged local action while minimizing systemic exposure and side effects. The origins of mesotherapy trace back to ancient needling practices in Chinese and Indian medicine, but its modern form was developed in 1952 by French physician Dr. Michel Pistor, who initially applied it to manage pain and vascular disorders using procaine injections. Pistor coined the term "mesotherapy" in 1958 through a publication in a local medical journal, and he founded the French Society of Mesotherapy in 1964, earning recognition as the "Father of Mesotherapy." By 1987, the French National Academy of Medicine had officially acknowledged it as an integrated medical specialty, leading to its widespread adoption across Europe, South America, Asia, and the United States, particularly for off-label applications. Mesotherapy is employed for a range of therapeutic and cosmetic purposes, including the treatment of localized musculoskeletal pain (such as , , and ), where randomized controlled trials have demonstrated statistically significant reductions in pain and improvements in function using lower drug doses compared to traditional methods. It is also used for , alopecia, and skin aging through biorejuvenation, as well as cosmetic goals like reduction and localized fat dissolution via lipolytic or ablative injections. In cosmetic contexts, substances such as are commonly injected to target subcutaneous fat, though effects are often temporary as fat cells can refill. Despite some evidence supporting its efficacy in and certain dermatological applications, mesotherapy's overall scientific validation remains limited by small sample sizes, lack of standardization in drug mixtures, and insufficient large-scale randomized trials, prompting calls for further research; recent systematic reviews as of 2024 continue to highlight promising results in areas like treatment but emphasize the need for more robust trials. Safety concerns include risks of , allergic reactions, and damage if performed without sterile conditions or by unqualified practitioners, necessitating and restriction to licensed medical professionals in jurisdictions like . In the United States, while individual components may be FDA-approved for other uses, mesotherapy itself lacks FDA approval for cosmetic fat reduction or treatments, and unapproved formulations have been linked to adverse reactions such as and scarring.

Overview

Definition

Mesotherapy is a minimally invasive medical technique that involves the administration of multiple microinjections of therapeutic substances directly into the or to achieve localized . The method was developed in by French physician Michel Pistor, who coined the term "mesotherapy" in 1958 and initially applied it for treating pain and vascular disorders. Etymologically, "mesotherapy" derives from the Greek words "mesos," meaning middle or intermediate, and "therapeia," referring to medical treatment, highlighting its focus on the middle layer of the skin, known as the . This layer, the primary that develops into connective tissues, muscles, and vascular structures, is targeted to promote direct therapeutic effects at the site of injection without widespread distribution. In contrast to systemic injections such as intravenous (IV) or intramuscular (IM) methods, which circulate drugs throughout the body and often require higher doses, mesotherapy employs superficial injections—typically no deeper than 4 mm—using minimal volumes of compounds to minimize side effects and enhance site-specific . Pistor himself described it as an approach of "little volume, few times, and in the right place," emphasizing its precision and reduced systemic exposure.

Principles

Mesotherapy operates on the principle that intradermal and subcutaneous injections stimulate the , the middle of embryonic origin that gives rise to connective s, to initiate reparative processes. The mechanical action of the needle induces microtrauma, triggering mechanotransduction pathways that activate local cellular responses, while the injected substances diffuse slowly into surrounding s to promote , enhanced lymphatic drainage, and overall tissue repair. This biological foundation posits that such stimulation fosters a regenerative by modulating the dermal and supporting vascular and lymphatic networks essential for nutrient delivery and waste removal. Pharmacologically, mesotherapy employs low-dose, multi-point delivery into the intradermal or subcutaneous layers to establish a localized "meso ," where the administered agents form a depot for gradual release over time. This approach contrasts with traditional oral or intravenous routes by minimizing systemic circulation and first-pass in the liver, thereby achieving higher local concentrations with substantially lower total drug volumes compared to . The sustained from this reservoir ensures prolonged therapeutic action at the target site, optimizing efficacy while curtailing widespread distribution. Central mechanisms include the enhanced local of injected compounds, which directly access the dermal vasculature and bypass hepatic processing, leading to more efficient uptake by resident cells. These injections activate key cellular components such as fibroblasts, which proliferate and synthesize to bolster integrity; adipocytes, which may undergo metabolic for localized remodeling; and immune cells, which contribute to inflammatory resolution. Through these interactions, mesotherapy theoretically amplifies reparative signaling, such as via glial cell in the , to coordinate and proliferative effects. The theoretical advantages of this methodology lie in its targeted intervention on layers, potentially reducing side effects associated with higher systemic doses, such as gastrointestinal upset or cardiovascular strain, by limiting exposure to non-target organs. By concentrating effects in the mesodermal structures, it aims for precise modulation of pathological processes like or localized , with a lower incidence of adverse events reported in principle due to the drug-sparing nature of the delivery.

History

Origins

The concept of injecting substances into the skin for therapeutic purposes has roots in ancient medical practices. Needle-based techniques date back to around 400 B.C., who used cactus spines for pain relief, and to , where has been practiced for over 2,000 years to stimulate healing. Similar dermal injection methods appear in ancient Indian traditions, though mesotherapy as a distinct modern technique was developed in by Michel Pistor, a , initially as a technique for treating vascular disorders and through targeted intradermal injections. Pistor, often regarded as the father of mesotherapy, drew from his clinical observations of patients with circulatory issues and persistent pain, seeking a method to deliver medications directly to affected tissues with minimal systemic effects. This approach emerged during a period when medicine was exploring localized therapies to improve efficacy while reducing side effects compared to traditional systemic administration. The technique was first formally described in in , when Pistor published an article in a local medical journal and coined the term "mesotherapy," deriving it from "" to reflect its focus on injecting into the middle of . In this publication, Pistor outlined the basic principles of administering small doses of active substances into the to achieve therapeutic effects at the site of , particularly for conditions involving poor circulation and . This marked the initial documentation of mesotherapy as a distinct medical practice, building on Pistor's earlier experiments with injections that unexpectedly improved hearing in an asthmatic , prompting further exploration of intradermal delivery. Early conceptualization of mesotherapy was influenced by a blend of homeopathic and allopathic traditions, emphasizing the use of minute, diluted doses to stimulate while incorporating . It also drew from established practices such as intradermal vaccination techniques, which demonstrated the efficacy of superficial skin injections for , and local anesthesia methods, like administration, to provide targeted pain relief without widespread distribution. These influences allowed Pistor to adapt existing knowledge into a polyvalent, regionalized that prioritized proximity to the for optimal drug action. A pivotal early publication formalizing mesotherapy for rheumatological applications appeared in 1964, when Pistor detailed its use in treating conditions like and related musculoskeletal pain through precise mesodermal injections. This work, published in association with his founding of the French Society of Mesotherapy, expanded the method's scope beyond vascular issues to broader rheumatic disorders, establishing a framework for its clinical application.

Development and Adoption

Following its inception in the mid-20th century, mesotherapy expanded within through formalized structures and applications beyond initial experimentation. In , Dr. Michel Pistor established the French Society of Mesotherapy to promote and regulate the technique, initially concentrating on for conditions such as and vascular disorders, with growing emphasis on for athletes' recovery and . This society facilitated , , and clinical adoption, laying the groundwork for mesotherapy's integration into French medical practice as a targeted intradermal . By the 1970s and 1980s, mesotherapy began spreading internationally, particularly to neighboring European countries like and , where national societies formed to adapt and localize the method for therapeutic uses in pain relief and . Its adoption extended to during this period, driven by cultural exchanges in medical practices and the technique's appeal for managing in resource-limited settings; for instance, it gained traction in countries such as and for musculoskeletal applications. By the , mesotherapy's popularity surged in across these regions, with practitioners increasingly applying it for localized fat reduction and skin rejuvenation, reflecting a broader shift toward non-invasive cosmetic interventions. A pivotal milestone occurred in 1987 when the French National Academy of Medicine recognized mesotherapy as an integral part of conventional medicine, affirming its legitimacy and encouraging wider clinical use. This endorsement spurred further global dissemination, including to the and Asian countries by the early , where it was incorporated into and protocols. In 2025, the International Consensus Guidelines on the Safe and of Mesotherapy were published, developed by a multidisciplinary panel from 16 countries under the Italian Society of Mesotherapy; these guidelines standardized protocols for intradermal injections, emphasized evidence-based applications in , , and , and promoted physician training to ensure safe adoption worldwide. The 2000s marked a significant in mesotherapy's focus, transitioning from predominantly therapeutic roles to prominent cosmetic applications, such as treatment and revitalization, amid rising demand for minimally invasive . This shift was supported by the establishment of dedicated training programs in —through institutions like the and Italian societies—and in , where academies in countries including and began offering certified courses on mesotherapy techniques, fostering professional standardization and broader practitioner accessibility.

Techniques

Procedure

Mesotherapy procedures begin with a thorough assessment to evaluate , identify contraindications such as disorders or active infections, and determine suitability for treatment. The skin in the target area is then disinfected using an alcohol-free to maintain aseptic conditions, while the practitioner wears disposable gloves and prepares sterile, single-use equipment including syringes and fine needles. Injection sites are selected and mapped based on the specific area being treated, such as outlining regions for localized concerns like , ensuring personalized placement according to factors like dermal thickness, age, and body region. The core of the procedure involves microinjections using fine needles, typically 27- to 32-gauge with lengths of 4 mm or 13 mm, inserted at a 30° angle to reach depths of 1-4 mm in the dermis or subcutaneous layer. Common techniques include intradermal point-by-point injections, where 0.02-0.05 mL of solution is administered perpendicularly at 1-2 cm intervals to form small papules, or the nappage method, which employs superficial spraying with a 45° angle and light wrist flick for broader coverage at about 2 mm depth. These can be performed manually for precision or with mechanical devices like mesoguns to facilitate multiple rapid injections, though multi-injectors are generally discouraged to ensure control and safety. A standard session entails 10-50 microinjections depending on the treatment area, lasting 15-30 minutes, with the patient positioned comfortably to access the site. Treatment courses typically involve 4-10 sessions spaced 1-2 weeks apart, adjusted based on clinical response, though acute cases may require fewer. Following injections, patients are monitored briefly for immediate reactions such as swelling or bruising, with ice packs applied if needed to reduce discomfort. Post-procedure instructions include avoiding sun exposure and strenuous activities for 24-48 hours, gentle of the area in subsequent days to prevent nodules, and documentation of any adverse events in the for follow-up.

Substances and Formulations

Mesotherapy employs a variety of substances categorized into vitamins, minerals, enzymes, hormones, and plant extracts, selected for their targeted physiological effects on and subcutaneous tissues. Vitamins, particularly the group including (B1), (B2), (B3), (B5), (B6), (B8), folic acid (B9), p-aminobenzoic acid (B10), and (B12), serve as coenzymes essential for cellular metabolism, energy production, and regeneration. Minerals such as contribute to muscle relaxation and enzymatic reactions supporting tissue repair. Enzymes, including proteolytic types like orgotein, facilitate tissue breakdown and reduce , while specifically aids in degrading matrices to enhance substance . Hormones, such as thyroxin, are occasionally incorporated to promote fat mobilization, though their use lacks robust clinical support. Plant extracts, exemplified by , stimulate synthesis and improve vascular integrity for enhanced firmness. Custom formulations in mesotherapy, often termed "cocktails," combine these substances in tailored mixtures to address specific indications, such as lipolytic blends containing , extract, and for fat reduction. A representative example is the NCTF135HA cocktail, comprising 53 ingredients including , , coenzymes, , and antioxidants, designed to replenish substrates depleted in aging skin. These polycomponent preparations must adhere to pharmacopeial standards for stability and to ensure therapeutic efficacy. Preparation of mesotherapy substances occurs in licensed pharmacies under strict aseptic conditions, utilizing double filtration sterilization to preserve heat-sensitive components like vitamins without compromising bioactivity. Dosages are precisely controlled, with typical volumes of 0.1 to 0.2 mL administered per injection site to minimize systemic absorption while maximizing local delivery. The evolution of mesotherapy formulations reflects a transition from to evidence-based actives, as outlined in the 2025 International Consensus Guidelines, which prioritize single-agent or well-studied combinations supported by clinical trials for safety and efficacy.

Applications

Cosmetic Uses

Mesotherapy is commonly employed off-label in cosmetic treatments for targeted fat reduction, particularly in areas of localized adiposity such as the and thighs, where intradermal injections of lipolytic agents like and deoxycholate are administered to disrupt cells and promote localized . However, is limited by small studies, and it lacks endorsement from recent consensus guidelines; in the United States, such injections are not FDA-approved and have been associated with adverse effects. These agents aim to reduce subcutaneous deposits without invasive surgery, often requiring multiple sessions to achieve effects, though the procedure is typically well-tolerated with minimal downtime. In skin rejuvenation, mesotherapy utilizes formulations, often combined with antioxidants, to enhance facial and aesthetics by improving hydration, elasticity, and wrinkle appearance through deep dermal delivery that stimulates production and tissue repair. Non-cross-linked is injected via techniques like serial micropuncture or , typically in 1-6 sessions spaced weekly to bimonthly, resulting in revitalized and reduced signs of . This approach is favored for its minimally invasive nature, providing gradual improvements in quality over several months with periodic maintenance. For treatment, mesotherapy targets dimpled skin on the buttocks and legs by injecting substances that enhance , reduce fluid retention, and promote synthesis, thereby smoothing the skin's uneven surface and decreasing hypodermal thickness. Clinical assessments using and scales like Nürnberger-Müller have shown reductions in severity following multiple intradermal sessions, with improvements in thigh circumference and dermal-hypodermal junction regularity. Mesotherapy for hair restoration involves scalp injections of growth factors and bioactive agents to combat androgenetic alopecia by stimulating dormant hair follicles, prolonging the anagen phase, and increasing hair density. Formulations may include autologous suspensions or combinations with minoxidil to enhance follicular nutrition and regeneration, administered in varied regimens across studies to yield visible regrowth. Mesotherapy has also been applied in dermatological conditions such as (particularly refractory cases), , and keloids through targeted intralesional injections to improve pigmentation, reduce , and minimize scarring, as endorsed by 2025 international consensus guidelines.

Medical Uses

Mesotherapy has been employed in for various musculoskeletal conditions, including and , through the intradermal or subcutaneous injection of anti-inflammatory agents, anesthetics, and muscle relaxants directly into affected areas. This approach allows for localized , potentially reducing systemic side effects while providing rapid relief and improved mobility in conditions such as , knee osteoarthritis, and . Clinical evidence indicates that mesotherapy is well-tolerated and effective for both acute and musculoskeletal , often outperforming oral therapies in targeted symptom reduction. In , mesotherapy supports recovery from injuries like patellar tendonitis, Achilles tendonitis, and muscle contractures by injecting anti-inflammatory and regenerative substances to alleviate localized pain and restore joint function, with evidence from clinical studies showing improved outcomes. In vascular disorders, mesotherapy targets conditions like and associated by administering vasodilators and antithrombotic substances to enhance circulation and alleviate symptoms such as swelling and pain. For instance, intradermal injections of agents like lymdiaral have shown promise in pilot studies for reducing fibrosclerotic damage in , serving as an adjunct to standard compression therapy. Recent guidelines endorse its use in painful edematous fibrosclerotic and venous management, emphasizing its role in preventing complications through localized . Neurological applications of mesotherapy include relief from cervicobrachialgia and fibromyalgia-associated via nerve-targeted injections of analgesics and compounds, which modulate local pathways potentially involving endorphin release and glial activity. Studies have demonstrated its in treating these conditions, with improvements in intensity and comparable to systemic treatments but with fewer adverse effects. Additionally, mesotherapy supports acceleration and reduction in clinical contexts by delivering regenerative substances like growth factors or anti-fibrotic agents to promote repair and minimize . Randomized trials have evaluated its impact on facial improvement, showing enhanced outcomes when combined with microencapsulated recombinant proteins. The 2025 international guidelines highlight mesotherapy's applicability in diverse clinical settings for such indications, though remains emerging and calls for further .

Efficacy and Evidence

Clinical Studies

Clinical studies on mesotherapy have primarily focused on its applications in , cosmetic fat reduction, and dermatological conditions, with varying levels of evidence derived from randomized controlled trials (RCTs) and s. A 2021 and of eight RCTs involving musculoskeletal disorders found moderate evidence supporting mesotherapy's efficacy for localized relief and functional improvement, demonstrating superior outcomes compared to systemic therapies, with a statistically significant reduction in scores (mean difference -1.45 on VAS ) and no serious adverse events reported. This review highlighted mesotherapy's role in conditions like chronic and shoulder periarthritis, where intradermal injections of analgesics and anti-inflammatories provided targeted relief. In contrast, evidence for mesotherapy in cosmetic fat reduction remains limited. A 2013 of available studies on localized adiposity treatments concluded that while some small-scale trials reported modest reductions in fat thickness (e.g., up to 2 cm in abdominal circumference after multiple sessions), the overall support was weak due to heterogeneous methodologies and short follow-up periods, with no large-scale RCTs confirming long-term efficacy. Recent developments include the 2025 International Consensus Guidelines on the safe and evidence-based use of mesotherapy in and , which cite multiple RCTs affirming its safety profile and moderate efficacy for localized musculoskeletal pain and certain skin conditions, recommending standardized protocols to enhance reproducibility. Ongoing research continues to explore its potential in hair regrowth for androgenetic alopecia, with preliminary data suggesting improved in small cohorts without significant side effects. Methodological challenges persist across studies, including small sample sizes (often n<50), inadequate blinding, and infrequent use of controls, which may inflate perceived benefits in aesthetic applications. effects have been particularly noted in trials for cosmetic outcomes, where subjective improvements in appearance were reported without objective volumetric changes. Overall, the evidence level is promising for mesotherapy in localized , supported by systematic reviews, but insufficient for broad cosmetic claims, as emphasized in multiple high-quality analyses lacking robust, long-term data.

Regulatory Status

In the United States, mesotherapy is not approved by the (FDA) for cosmetic or therapeutic applications and is classified as an . The FDA has specifically warned against unproven fat-dissolving injections associated with mesotherapy, citing risks of adverse reactions from non-approved substances. In , mesotherapy is recognized as a legitimate in , its country of origin, and , though with strict oversight on indications such as fat reduction, which faced temporary prohibitions before regulatory adjustments. Italian law mandates that intradermal injections be performed exclusively by qualified physicians, as affirmed by judgments. Under broader pharmaceutical regulations, mesotherapy requires administration by licensed practitioners and the use of sterile, properly compounded substances to ensure compliance with good manufacturing practices. Mesotherapy is widely practiced for aesthetic uses in and , subject to oversight by the Agência Nacional de Vigilância Sanitária (ANVISA) and the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) on injectables and aesthetic procedures, supporting its integration into cosmetic practices in these markets. Regulatory approaches in remain varied across countries, with procedures often subject to approvals for injectables, and ongoing efforts toward . The 2025 International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy, developed by a multidisciplinary panel of experts from 16 countries, advocate for evidence-based protocols, only with robust clinical support, and mandatory practitioner to promote global harmonization and safety.

Safety and Criticism

Risks and Side Effects

Mesotherapy, while generally considered a low-risk procedure when performed correctly, is associated with a range of potential adverse effects, primarily due to the invasive nature of multiple injections and the variability of injected substances. Common side effects include bruising, swelling, pain at the injection sites, and temporary pigmentation changes such as dark patches or redness, which typically resolve within 1 to 7 days without intervention. These reactions are common, stemming from the mechanical of needle insertion and the inflammatory response to the injected agents. More serious risks encompass infections arising from non-sterile needles or contaminated substances, allergic reactions to the injected materials, and embolism resulting from inadvertent vascular injection. Infections, including outbreaks of nontuberculous mycobacterial subcutaneous infections, have been documented in clinical settings where aseptic protocols were inadequate. More recent outbreaks, such as a 2023 cluster of Mycobacterium abscessus infections linked to mesotherapy in a beauty center, underscore the ongoing risks from inadequate sterilization. Allergic responses may manifest as immediate or delayed hypersensitivity, particularly to components like lecithin, while embolic events, such as those seen in Nicolau syndrome, involve drug-induced occlusion of cutaneous arteries leading to livedoid dermatitis. Rare complications include skin necrosis, granulomas, and , often linked to improper formulations or of substances, with elevated risks in cosmetic fat-dissolving procedures due to deeper injections and lipolytic agents. may present as tissue death with formation, while granulomas form as foreign body reactions to injected particles, occurring at rates as low as 0.04% for hyaluronic acid-based formulations but higher with unapproved mixtures. Adherence to 2025 international consensus guidelines significantly mitigates these risks through the use of sterile disposable equipment, and approved injectable agents, rigorous aseptic techniques, and structured post-care protocols including monitoring and avoidance of anti-inflammatory medications pre-treatment. These measures, including and documentation of procedures, promote safety across clinical settings and reduce the incidence of adverse events when followed by qualified practitioners.

Criticisms

Mesotherapy has faced significant criticism for its lack of , as practitioners often use custom "cocktails" of ingredients without established protocols for , dosage, or techniques, leading to inconsistent outcomes and potential variability in results. This variability is compounded by the arbitrary selection of compounds, such as vitamins, enzymes, hormones, and herbal extracts, whose in intradermal or subcutaneous delivery remain poorly understood. Critics highlight substantial evidence gaps, with accusations of hype in cosmetic applications despite a paucity of robust randomized controlled trials (RCTs) supporting its efficacy for conditions like reduction or skin rejuvenation. The U.S. (FDA) has issued warnings since the 2000s against unproven claims for mesotherapy and related injection procedures, noting that none of the formulations are approved for fat dissolution or aesthetic uses, and emphasizing the absence of scientific validation for advertised benefits. Ethical concerns arise from the potential for , particularly in unregulated settings like spas where non-physicians may overpromote mesotherapy without adequate medical oversight, exploiting patients with unsubstantiated promises of non-invasive fat loss or rejuvenation. Such practices raise issues of and patient , as the technique's often relies on anecdotal testimonials rather than verifiable , undermining in legitimate dermatological care. Professional opinions remain divided: while the French Society of Mesotherapy endorses its use for and certain localized conditions, viewing it as a valid minimally invasive approach, major dermatological bodies like the dismiss it as unnecessary and ineffective, particularly for cosmetic indications, due to insufficient evidence of benefits outweighing risks.

References

  1. [1]
    Mesotherapy: From Historical Notes to Scientific Evidence and ...
    May 1, 2020 · Intradermal therapy, known as mesotherapy, is a technique used to inject a drug into the surface layer of the skin. In particular, it involves ...
  2. [2]
    Mesotherapy – The french connection - PMC - NIH
    Mesotherapy involves the use of multiple intradermal or subcutaneous injections of a mixture of compounds in minute doses, by means of very fine needles.
  3. [3]
    Mesotherapy for local fat reduction - PubMed
    Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French ...Missing: definition | Show results with:definition
  4. [4]
    Fat-Dissolving Injections That Are Not FDA Approved Can Be Harmful
    Dec 20, 2023 · FDA has received reports of consumers who have used fat-dissolving injections that are not FDA approved and that have caused adverse reactions (bad side ...
  5. [5]
    Mesotherapy as a Promising Alternative to Minoxidil for ... - NIH
    May 5, 2024 · Mesotherapy for AGA treatment has been explored and utilized in some clinics; however, it has not been approved by the US FDA. However, ...
  6. [6]
    Mesotherapy: What is new?
    Pistor coined the term "mesotherapy." He defined it as treatment of the mesoderm (the primary germ layer that develops into connective tissue, muscle and ...Missing: etymology | Show results with:etymology
  7. [7]
    Uncovering the Myth of Mesotherapy - Plastic Surgery Practice
    The word “mesotherapy” is derived from the Greek words “meso,” meaning medium or middle, and “therapy,” meaning treatment. In this case, the word “meso” refers ...Missing: definition etymology
  8. [8]
    Polycomponent mesotherapy formulations for the treatment of skin ...
    Mesotherapy is a technique that involves micro-injections of therapeutic substances, such as hyaluronic acid, vitamins, minerals, and amino acids into the ...
  9. [9]
    [PDF] Modulating lipolysis for nutraceutical and cosmeceutical applications
    Mar 17, 2006 · Michel Pistor ... Since the tissue into which he was injecting came from mesodermal origin, he called this technique mesotherapy (Pistor,. 1964).
  10. [10]
    Mesotherapy: From Historical Notes to Scientific Evidence and ...
    May 1, 2020 · The Italian Mesotherapy Society proposes this position paper to apply intradermal therapy based on scientific evidence and no longer on personal ...Missing: spread adoption Spain America
  11. [11]
    International Consensus Guidelines on the Safe and Evidence ...
    Mesotherapy involves a series of microinjections in a specific area of the skin. Injection depth has been a topic of much debate, but the highest level of ...Missing: neovascularization drainage
  12. [12]
    International Consensus Guidelines on the Safe and Evidence ... - NIH
    Mesotherapy involves a series of microinjections in a specific area of the skin. Injection depth has been a topic of much debate, but the highest level of ...
  13. [13]
    Mesotherapy: Procedure, Side Effects, and More - Healthline
    Aug 11, 2017 · Mesotherapy is a technique that uses injections of vitamins, enzymes, hormones, and plant extracts to rejuvenate and tighten skin, as well as remove excess fat.Missing: protocol | Show results with:protocol<|control11|><|separator|>
  14. [14]
    Mesotherapy: Overview - SpringerLink
    Oct 31, 2025 · It allows for the direct application of medications to affected areas through intradermal injections.Missing: influences allopathic
  15. [15]
    Mesotherapy - DermNet
    Mesotherapy is a nonsurgical, permanent method for fat removal, body contouring and is also used for hair loss and skin ageing.Missing: drainage repair
  16. [16]
    All about mesotherapy cocktails - Dermabiotecnica
    Aug 16, 2023 · The ingredients of the lipolytic cocktail against cellulite may include procaine, artichoke extract, caffeine, yohimbine, buflomedil, organic ...
  17. [17]
    Employing hyaluronic acid-based mesotherapy for facial rejuvenation
    Mesotherapy with HA-based fillers is a favorable method for restoring youthful appearance, rejuvenation, and revitalization of skin.Missing: clinical | Show results with:clinical
  18. [18]
    Efficacy of intradermal mesotherapy in cellulite reduction - PubMed
    Results: Intradermal mesotherapy reduced severity of cellulite. The surface area of serrated hypodermis-dermis junction and hypodermis thickness decreased ...
  19. [19]
    Systematic review of mesotherapy: a novel avenue for the treatment ...
    To date, mesotherapy using 6 classes of agents and their combinations have been studied; this includes dutasteride, minoxidil, growth factors or autologous ...Missing: restoration | Show results with:restoration
  20. [20]
    Mesotherapy in the treatment of musculoskeletal pain in rehabilitation
    Jul 30, 2019 · Mesotherapy showed a good effect to reduce acute and chronic musculoskeletal pain and, also, it is a well-tolerated treatment.Missing: wound | Show results with:wound
  21. [21]
    Role of Mesotherapy in Musculoskeletal Pain - PubMed Central - NIH
    Mesotherapy is the injection of active substances into the surface layer of the skin. This method allows a slower spread, higher levels, and longer lasting ...
  22. [22]
    Intradermal therapy (mesotherapy) with lymdiaral in chronic venous ...
    Intradermal therapy (mesotherapy) with lymdiaral in chronic venous insufficiency and associated fibrosclerotic edema damage: a pilot study · Abstract.Missing: vascular | Show results with:vascular
  23. [23]
    Mesotherapy versus oral medical treatment of chronic venous ...
    Mar 27, 2025 · Mesotherapy involves the introduction of drugs through dermal microinjections for preventive, therapeutic, or rehabilitative purposes.
  24. [24]
    CLINICAL EVALUATION OF MESOTHERAPY ON THE ...
    Aug 6, 2025 · ... wound healing with the potential of minimizing scar formation. This study aims to investigate the effect of microencapsulated recombinant ...
  25. [25]
    A systematic review of randomized controlled trials with meta-analysis
    Apr 27, 2021 · Conclusion: Mesotherapy proved to be more effective than systemic therapy in the treatment of local pain and functional limitations caused by a ...
  26. [26]
    International Consensus Guidelines on the Safe and Evidence ...
    Jul 2, 2025 · International Consensus Guidelines on the Safe and Evidence-Based Practice of Mesotherapy: A Multidisciplinary Statement. J Clin Med. 2025 Jul 2 ...
  27. [27]
  28. [28]
    [PDF] ASPS Policy Statement on Mesotherapy/Injection Lipolysis
    5. As there are no agreed upon standards (except for Kybella), physicians administering mesotherapy treatments should be aware of the chemicals/drugs being ...Missing: pharmacopeia | Show results with:pharmacopeia
  29. [29]
    [PDF] a consensus report from the Italian Society of Mesotherapy
    Used correctly, mesotherapy is effective in the treatment of painful musculoskeletal conditions, chronic ve- nous lymphatic insufficiency (CVLI), oedema- tous ...
  30. [30]
    Latin America Mesotherapy Market Size & Outlook, 2021-2028
    Asia Pacific is the fastest growing regional market and is projected to reach USD 291.6 million by 2028. Key Regions: Brazil , U.S. , UK , Japan , Mexico.
  31. [31]
  32. [32]
    SAFETY AND EFFICACY OF MESOTHERAPY IN ... - NIH
    Mesotherapy proved efficient in treatment of local pain and functional limitations caused by a variety of musculoskeletal conditions, and a statistically ...
  33. [33]
    Mesotherapy Side Effects: Risks, Safety & How to Minimize Them
    Common, Temporary Side Effects. Most patients experience mild reactions that resolve within 24-72 hours: 1. Redness & Swelling. Frequency: 90% of cases ...
  34. [34]
    Outbreak of Mesotherapy-Associated Skin Reactions - CDC
    Nov 11, 2005 · The findings from this investigation determined that 14 women had prolonged skin reactions after mesotherapy injections of non-FDA--approved ...Missing: embolism | Show results with:embolism
  35. [35]
    [A rare side effect of mesotherapy: Nicolau syndrome] - PubMed
    Aug 6, 2013 · Nicolau dermatitis is a rare skin complication described as occurring mainly as a result of intramuscular injections.Missing: infection | Show results with:infection
  36. [36]
    Outbreak of Nontuberculous Mycobacterial Subcutaneous Infections ...
    We describe an outbreak of severe subcutaneous infections due to nontuberculous mycobacteria following mesotherapy. Epidemiological studies and molecular ...
  37. [37]
    Ischemic colitis after mesotherapy combined with anti-obesity ... - NIH
    However, there is a tendency to disregard their various adverse effects. Adverse effects of mesotherapy include bruising, edema, skin necrosis, abdominal ...
  38. [38]
    Mesotherapy: Safety profile and management of complications
    Aug 24, 2019 · Despite being considered as a relatively safe method, a series of adverse reactions can occur due to its wide application and lack of standardization processes.Abstract · INTRODUCTION · RESULTS · CONCLUSIONS
  39. [39]
    Mesotherapy-Induced Cutaneous Foreign Body-Type ... - NIH
    Apr 3, 2023 · Mesotherapy induces infectious and noninfectious complications. ... necrosis, cyst formation, ulcer formation and alopecia.Missing: embolism | Show results with:embolism
  40. [40]
    Infected Skin Necrosis after Mesotherapy.
    Mar 1, 2008 · The infection finding was swelling, reddish to purple color change and bullae formation. As time goes by, skin necrosis and eschar formation ...Missing: embolism | Show results with:embolism
  41. [41]
    Concerns about drug efficacy, safety surround mesotherapy
    She notes that there is a lack of standardization in these tailor-made cocktails. "For male pattern baldness, cocktails can include finasteride, T3 ...
  42. [42]
    Position paper on mesotherapy
    This position paper has examined the available evidence and finds that acceptable scientific evidence for its effectiveness and safety is lacking.
  43. [43]
    A Cautious Look at Mesotherapy for Fat Reduction - Quackwatch
    Apr 21, 2008 · Quackwatch. Your Guide to Quackery, Health Fraud, and Intelligent Decisions ... dermatologists in the United States have warned against ...
  44. [44]
    Mesotherapy Not Proven As a Safe Alternative to Liposuction
    Nov 29, 2007 · Touted as a nonsurgical alternative to liposuction, mesotherapy involves injecting medications and plant extracts into layers of fat and ...
  45. [45]
    SOCIETE FRANCAISE DE MESOTHERAPIE DEFINITION - SOINS ...
    La MÉSOTHÉRAPIE est indiquée surtout : EN RHUMATOLOGIE · La MÉSOTHÉRAPIE est un traitement de la douleur dans : l'ARTHROSE, LES TENDINOPATHIES · En MÉDECINE DU ...En pratique · Hygiène · DIU de Mesotherapie · Matériel
  46. [46]
    Cellulite treatments: What really works?
    Mesotherapy. During this procedure, you receive a series of injections in the area(s) with cellulite. Different substances are injected into the area ...